Sign In
Buy TMCI
$4.31
-0.0700 (-1.60%)
At Close: Jul 31, 2026
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results
07:05am, Friday, 27'th Feb 2026
PONTE VEDRA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference
07:05am, Tuesday, 24'th Feb 2026
PONTE VEDRA, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
First Eagle Small Cap Opportunity Fund Q4 2025 Portfolio Review
02:27pm, Thursday, 19'th Feb 2026
First Eagle Small Cap Opportunity Fund A Shares (without sales charge*) posted a return of 1.71% in fourth quarter 2025. Small Cap Opportunity Fund A Shares (without sales charge*) posted a return of
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026
05:13pm, Thursday, 12'th Feb 2026
PONTE VEDRA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
301,100 Shares in Treace Medical Concepts, Inc. $TMCI Acquired by Acuitas Investments LLC
03:03am, Friday, 30'th Jan 2026
Acuitas Investments LLC purchased a new position in Treace Medical Concepts, Inc. (NASDAQ: TMCI) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Comm
Treace Medical Concepts, Inc. (TMCI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
12:56pm, Wednesday, 14'th Jan 2026
Treace Medical Concepts, Inc. (TMCI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
07:05am, Tuesday, 13'th Jan 2026
PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology
04:05pm, Thursday, 08'th Jan 2026
PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
Treace Medical Concepts (NASDAQ:TMCI) Trading Down 0.8% – Time to Sell?
02:07am, Saturday, 27'th Dec 2025
Shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI - Get Free Report) traded down 0.8% on Friday. The stock traded as low as $2.41 and last traded at $2.42. 692,875 shares were traded during mid-da
Treace Medical Secures Up to $175 Million in Debt Financing
08:30am, Thursday, 18'th Dec 2025
New 5-Year Agreement Provides Continued Financial Strength & Flexibility New 5-Year Agreement Provides Continued Financial Strength & Flexibility
SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether certain officers and directors of Quantum Computing Inc. (NASDAQ: QUBT), Quanex Building Products Corporation
Treace Medical Concepts, Inc. (TMCI) Q3 2025 Earnings Call Transcript
11:36am, Friday, 07'th Nov 2025
Treace Medical Concepts, Inc. ( TMCI ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Trip Taylor John Treace - Founder, Chairman & CEO Mark Hair - Chief Financial Officer Con
Treace Announces Participation in Two Upcoming Investor Conferences
08:05am, Friday, 07'th Nov 2025
PONTE VEDRA, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
Treace Medical Concepts (TMCI) Reports Q3 Loss, Beats Revenue Estimates
06:41pm, Thursday, 06'th Nov 2025
Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to a loss of $0.25 per share a year ago.
Y Intercept Hong Kong Ltd Raises Stake in Treace Medical Concepts, Inc. $TMCI
03:41am, Monday, 03'rd Nov 2025
Y Intercept Hong Kong Ltd lifted its stake in shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) by 645.8% in the undefined quarter, according to its most recent 13F filing with the Securities and
